Palliative Therapie des Glioblastoma multiforme: ein multimodales Konzept

2006 ◽  
Vol 156 (9-10) ◽  
pp. 255-259
Author(s):  
Viktoria Faber ◽  
Ralf Thödtmann ◽  
Christine Marosi
2013 ◽  
Vol 51 (01) ◽  
Author(s):  
P Breitfeld ◽  
T Werner ◽  
K Johanniemann ◽  
AW Lohse ◽  
A Koops ◽  
...  
Keyword(s):  

2014 ◽  
Vol 226 (06) ◽  
Author(s):  
D William ◽  
M Linnebacher ◽  
CF Classen

2016 ◽  
Vol 228 (06/07) ◽  
Author(s):  
D William ◽  
M Walther ◽  
B Schneider ◽  
CF Classen

2012 ◽  
Vol 40 (05) ◽  
pp. 333-340
Author(s):  
M. Kessler ◽  
B. Kandel-Tschiederer ◽  
A. Schwietzer

Zusammenfassung Gegenstand und Ziel: Kombinationstherapie von kaninen intranasalen Tumoren mit palliativer 60Cobalt-Strahlentherapie und adjuvanter systemischer Chemotherapie. Material und Methode: 25 Hunde wurden von 2004 bis 2006 in der Tierklinik Hofheim mit einer Gesamtstrahlendosis von 24 Gy (drei Fraktionen à 8 Gy, Tag 0, 7, 21) und Carboplatin (fünf Applikationen zu je 270–300 mg/m2 KOF intravenös im Abstand von 21–28 Tagen) behandelt. Ergebnisse: 88% der Patienten zeigten eine Verbesserung der klinischen Symptome (Nasenausfluss, respiratorische Symptome). Bei fünf Hunden ließ sich eine partielle und bei weiteren fünf eine komplette Tumorremission erreichen. Die Chemotherapie wurde gut toleriert. Die Bestrahlung führte zu keinen oder nur minimalen Nebenwirkungen mit Ausnahme von drei Patienten, bei denen es zur Erblindung nach Mitbestrahlung eines Auges kam, und einem weiteren Patienten mit epileptischen Anfällen. Die mediane Überlebenszeit lag bei 156 Tagen (Range 10–639 Tage). Zwischen den untersuchten Parametern (Rasse, Alter, Geschlecht, histologischer Tumortyp, Ausdehnung des Tumors ins Gehirn, Tumorstadium) und der progressionsfreien Zeit bzw. der Überlebenszeit ergab sich keine statistisch signifikante Korrelation. Patienten mit Tumorremission hatten eine signifikant längere Überlebenszeit als Patienten mit stabiler Erkrankung. Schlussfolgerung und klinische Relevanz: Es konnte eine sehr gute Palliation der Symptome mit akzeptablen Überlebenszeiten erreicht werden. Ein Therapievorteil gegenüber einer alleinigen Bestrahlung durch die Kombination der Bestrahlung mit adjuvanter Chemotherapie war beim Vergleich mit entsprechender Literatur nicht zu belegen.


2012 ◽  
Vol 54 (03) ◽  
pp. 189
Author(s):  
Inmaculada Soler Ferrero ◽  
Juan José Hidalgo Mora ◽  
Marta Molina Planta ◽  
José María Vila Vives ◽  
Andrés Baamonde Vidarte ◽  
...  

2019 ◽  
Vol 1 (2) ◽  
pp. V1
Author(s):  
Sima Sayyahmelli ◽  
Jian Ruan ◽  
Bryan Wheeler ◽  
Mustafa K. Başkaya

Primary glioblastoma multiforme tumors of the medulla oblongata are rare, especially in the adult population. Perhaps due to this rarity, we are not aware of any previous reports addressing the resection of these tumors or their clinical outcomes.In this surgical video, we present a 43-year-old man with a 1-month history of left-sided paresthesia. The paresthesia initiated in the left hand, along with weakness and reduced fine motor control, and then spread to the entire left side of the body. He had recent weight loss, imbalance, difficulty in swallowing, and hoarseness in his voice. He also had a diminished gag reflex, and significant atrophy of the right side of the tongue with an accompanying deviation of the uvula and fasciculations of the tongue. MRI showed an infiltrative expansile mass within the medulla with peripheral enhancement and central necrosis. In T2/FLAIR sequences, a hyperintense signal extended superiorly into the left inferior aspect of the pons and left inferior cerebellar peduncle and inferiorly into the upper cervical cord.The decision was made to proceed with surgical resection. The patient underwent a midline suboccipital craniotomy with C1 laminectomy for surgical resection of this infiltrative expansile intrinsic mass in the medulla oblongata, with concurrent monitoring of motor and somatosensory evoked potentials and monitoring of lower cranial nerves IX, X, XI, and XII. A gross-total resection of the enhancing portion of the tumor was performed, along with a subtotal resection of the nonenhancing portion. The surgery and postoperative course were uneventful. Histopathology revealed a grade IV astrocytoma. The patient received radiation therapy.In this surgical video, we demonstrate important steps for the microsurgical resection of this challenging glioblastoma multiforme of the medulla oblongata.The video can be found here: https://youtu.be/QHbOVxdxbeU.


1998 ◽  
Vol 89 (1) ◽  
pp. 60-68 ◽  
Author(s):  
Richard B. Schwartz ◽  
B. Leonard Holman ◽  
Joseph F. Polak ◽  
Basem M. Garada ◽  
Marc S. Schwartz ◽  
...  

Object. The study was conducted to determine the association between dual-isotope single-photon emission computerized tomography (SPECT) scanning and histopathological findings of tumor recurrence and survival in patients treated with high-dose radiotherapy for glioblastoma multiforme. Methods. Studies in which SPECT with 201Tl and 99mTc-hexamethypropyleneamine oxime (HMPAO) were used were performed 1 day before reoperation in 47 patients with glioblastoma multiforme who had previously been treated by surgery and high-dose radiotherapy. Maximum uptake of 201Tl in the lesion was expressed as a ratio to that in the contralateral scalp, and uptake of 99mTc-HMPAO was expressed as a ratio to that in the cerebellar cortex. Patients were stratified into groups based on the maximum radioisotope uptake values in their tumor beds. The significance of differences in patient gender, histological characteristics of tissue at reoperation, and SPECT uptake group with respect to 1-year survival was elucidated by using the chi-square statistic. Comparisons of patient ages and time to tumor recurrence as functions of 1-year survival were made using the t-test. Survival data at 1 year were presented according to the Kaplan—Meier method, and the significance of potential differences was evaluated using the log-rank method. The effects of different variables (tumor type, time to recurrence, and SPECT grouping) on long-term survival were evaluated using Cox proportional models that controlled for age and gender. All patients in Group I (201Tl ratio < 2 and 99mTc-HMPAO ratio < 0.5) showed radiation changes in their biopsy specimens: they had an 83.3% 1-year survival rate. Group II patients (201T1 ratio < 2 and 99mTc-HMPAO ratio of ≥ 0.5 or 201Tl ratio between 2 and 3.5 regardless of 99mTc-HMPAO ratio) had predominantly infiltrating tumor (66.6%); they had a 29.2% 1-year survival rate. Almost all of the patients in Group III (201Tl ratio > 3.5 and 99mTc-HMPAO ratio ≥ 0.5) had solid tumor (88.2%) and they had a 6.7% 1-year survival rate. Histological data were associated with 1-year survival (p < 0.01); however, SPECT grouping was more closely associated with 1-year survival (p < 0.001) and was the only variable significantly associated with long-term survival (p < 0.005). Conclusions. Dual-isotope SPECT data correlate with histopathological findings made at reoperation and with survival in patients with malignant gliomas after surgical and high-dose radiation therapy.


Sign in / Sign up

Export Citation Format

Share Document